by Lyla El-Fayomi | Jul 30, 2021
“Regenerative medicine news under the microscope” is a monthly feature highlighting big stories in stem cell research. I will sample the latest and greatest findings in recent press and package them into a single post. July was another great month in regenerative...
by Tara Fernandez | Jul 7, 2021
In early 2021, a young boy in Barcelona was the first to receive Pfizer’s investigational gene therapy for Duchenne muscular dystrophy (DMD). This was part of a global Phase 3 human trial to test Pfizer’s lead candidate, PF-06939926, in a cohort of 99 patients with...
by Lyla El-Fayomi | Apr 30, 2021
“Regenerative medicine news under the microscope” is a new monthly feature highlighting big stories in stem cell research. I will sample the latest and greatest findings in recent press and package them into a single post. This month, I am featuring more COVID-19...
by Stacey Johnson | Mar 26, 2021
Is it normal to have a pet disease? Ever since I did a project on epilepsy in grade 4, I’ve had an interest in this disorder that affects one percent of the Canadian population, and worldwide there are anywhere from 50-65 million people living with epilepsy,...
by Stacey Johnson | Mar 19, 2021
The more attention stem cells, cell therapies and gene therapies get, the more education there needs to be so the public can differentiate between approved and unapproved treatments. At this time, there are over 1,220 clinical trials ongoing worldwide (including...
Comments